Effects of Bone Morphogenetic Protein Agonist Small Molecule, SB4, on Osteogenic Differentiation of Adipose-Derived Mesenchymal Stem Cells
These results indicate that SB4, with potential BMP-like activity, induces OS differentiation of ADMSCs, leading it to serve as a cost-effective BMP agonist for osteogenesis-related research as well as a potential therapeutic agent for bone repair and regeneration.
Authors
- Bahman Zeynali (ORCID: https://orcid.org/0000-0002-5112-4287)
- Iman Shabani (ORCID: https://orcid.org/0000-0003-2614-3088)
- Azita Parvaneh Tafreshi (ORCID: https://orcid.org/0000-0001-6563-4969)
- Fatemeh Naghshnejad
Institutions
- Amirkabir University of Technology (IR)
- University of Tehran (IR)
- National Institute of Genetic Engineering and Biotechnology (IR)
Publication Details
- Journal
- Journal of Bone Metabolism
- Published
- 2026-02-28
- DOI
- https://doi.org/10.11005/jbm.25.899
- Primary Topic
- TGF-β signaling in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00